As glycine is present in the formulation, ULTIVA is contraindicated for epidural and intrathecal use (see Pharmacology: Toxicology: Pre-Clinical Safety Data under Actions).
ULTIVA is contraindicated in patients with known hypersensitivity to any component of the preparation and other fentanyl analogues.